National Cancer Institute; Notice of Closed Meetings, 8331-8332 [2015-03092]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices
Contact Person: Sally Eckert-Tilotta, Ph.D.,
Scientific Review Officer, National Institute
of Environmental Health Sciences, Office of
Program Operations, Scientific Review
Branch, P.O. Box 12233, Research Triangle
Park, NC 27709, (919) 541–1446, eckertt1@
niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: February 10, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–03094 Filed 2–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Aging Special Emphasis Panel, April 06,
2015, 11:00 a.m. to April 06, 2015, 1:00
p.m., National Institute on Aging,
Gateway Building, 7201 Wisconsin
Avenue, Suite 2C212, Bethesda, MD
20892 which was published in the
Federal Register on February 9, 2015,
80 FR 7003.
The meeting notice is amended to
change the date of the meeting from
April 6, 2015 to March 30, 2015. The
meeting is closed to the public.
Dated: February 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–03091 Filed 2–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
VerDate Sep<11>2014
16:51 Feb 13, 2015
Jkt 235001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant and/or proposal
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; R13
Conference Grant Review.
Date: March 3, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W556, Rockville, MD 20850, 240–276–6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Core
Infrastructure & Methodological Research for
Cancer Epidemiology Cohorts (U01).
Date: March 12, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
6W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Viatcheslav A.
Soldatenkov, Ph.D., M.D., Scientific Review
Officer, Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W254, Bethesda, MD 20892–8329, 240–276–
6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Vacutubes
to Preserve the Viability of Circulating Tumor
Cells.
Date: March 19, 2015.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W538, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D., Health
Scientist Administrator, Program & Review
Extramural Staff Training Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W534, Bethesda, MD 20892–9750, 240–276–
6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Predictive
Biomarkers of Adverse Reactions to
Radiation Treatment.
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
8331
Date: March 20, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W538, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Ivan Ding, M.D. Health
Scientist Administrator, Program & Review
Extramural Staff Training Branch, Division of
Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room
7W534, Bethesda, MD 20892–9750, 240–276–
6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI Small
Grants Program for Cancer Research.
Date: March 24–25, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Viatcheslav A.
Soldatenkov, Ph.D., M.D., Scientific Review
Officer, Special Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W254, Bethesda, MD 20892–8329,
240–276–6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; AIDs
Malignancy Consortium (AMC).
Date: March 26–27, 2015.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Bratin K. Saha, Ph.D.,
Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W556, Rockville, MD 20850, 240–
276–6411, sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Intervention and Surveillance Modeling.
Date: April 1–2, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W554, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Christopher L. Hatch,
Ph.D., Chief, Health Scientific Administrator,
Program Coordination and Referral Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W554, Rockville, MD 20850,
240–276–6454, ch29v@nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
E:\FR\FM\17FEN1.SGM
17FEN1
8332
Federal Register / Vol. 80, No. 31 / Tuesday, February 17, 2015 / Notices
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–03092 Filed 2–13–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Extracellular Vesicles in HIV/AIDS and
Substance Abuse (R01, R21).
Date: February 26, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Jagadeesh S. Rao, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exploratory Studies of Smoking Cessation
Interventions for People with Schizophrenia
(R21/R33).
Date: March 3, 2015.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
VerDate Sep<11>2014
16:51 Feb 13, 2015
Jkt 235001
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Jagadeesh S. Rao, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4234, MSC 9550, Bethesda, MD 02892, 301–
443–9511, jrao@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Core ‘‘Center of Excellence’’ Grant Program
(P30).
Date: March 10, 2015.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIAID Conference Center, 5609
Fisher’s Lane, Rockville, MD 20852.
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105, rogersn2@
nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Research ‘‘Center of Excellence’’ Grant
Program (P50).
Date: March 11, 2015.
Time: 8:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIAID Conference Center, 5609
Fisher’s Lane, Rockville, MD 20852.
Contact Person: Nadine Rogers, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4229, MSC 9550, Bethesda, MD
20892–9550, 301–402–2105, rogersn2@
nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; R13
Conference Grant Review (PA13–347).
Date: March 17, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892–9550, 301–
435–1432, liangm@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Loan
Repayment 2015.
Date: March 30, 2015.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Lyle Furr, Scientific
Review Officer, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
PO 00000
Frm 00048
Fmt 4703
Sfmt 9990
DHHS, Room 4227, MSC 9550, 6001
Executive Boulevard, Bethesda, MD 20892–
9550, (301) 435–1439, lf33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Interventions for Youth Who Misuse/Abuse
Prescription Stimulant Medications in High
School and/or College-Attending Youth
(U01).
Date: March 31, 2015.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; The
National Drug Abuse Treatment Clinical
Trials Network (UG1).
Date: March 31, 2015.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Contact Person: Jose F. Ruiz, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, Room 4228, MSC 9550,
6001 Executive Blvd., Bethesda, MD 20892–
9550, (301) 451–3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Avenir
Award Program for Genetics or Epigenetics of
Substance Abuse (DP2).
Date: April 13, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Gerald L. McLaughlin,
Ph.D., Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Blvd., Room 4238, MSC 9550, Bethesda, MD
20892–9550, 301–402–6626, gm145a@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 9, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–03095 Filed 2–13–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\17FEN1.SGM
17FEN1
]]>Agencies
[Federal Register Volume 80, Number 31 (Tuesday, February 17, 2015)]
[Notices]
[Pages 8331-8332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-03092]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant and/or proposal applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; R13 Conference Grant Review.
Date: March 3, 2015.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Core Infrastructure & Methodological Research for Cancer
Epidemiology Cohorts (U01).
Date: March 12, 2015.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 6W032, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D.,
Scientific Review Officer, Special Review Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Vacutubes to Preserve the Viability of Circulating Tumor
Cells.
Date: March 19, 2015.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Ivan Ding, M.D., Health Scientist Administrator,
Program & Review Extramural Staff Training Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444,
dingi@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Predictive Biomarkers of Adverse Reactions to Radiation
Treatment.
Date: March 20, 2015.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W538, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Ivan Ding, M.D. Health Scientist Administrator,
Program & Review Extramural Staff Training Branch, Division of
Extramural Activities, National Cancer Institute, 9609 Medical
Center Drive, Room 7W534, Bethesda, MD 20892-9750, 240-276-6444,
dingi@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Small Grants Program for Cancer Research.
Date: March 24-25, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Viatcheslav A. Soldatenkov, Ph.D., M.D.,
Scientific Review Officer, Special Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; AIDs Malignancy Consortium (AMC).
Date: March 26-27, 2015.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Bratin K. Saha, Ph.D., Scientific Review
Officer, Program Coordination and Referral Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W556, Rockville, MD 20850, 240-276-6411,
sahab@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Intervention and Surveillance Modeling.
Date: April 1-2, 2015.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W554, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Christopher L. Hatch, Ph.D., Chief, Health
Scientific Administrator, Program Coordination and Referral Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W554, Rockville, MD 20850, 240-276-
6454, ch29v@nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction;
[[Page 8332]]
93.393, Cancer Cause and Prevention Research; 93.394, Cancer
Detection and Diagnosis Research; 93.395, Cancer Treatment Research;
93.396, Cancer Biology Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399, Cancer Control, National
Institutes of Health, HHS)
Dated: February 10, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-03092 Filed 2-13-15; 8:45 am]
BILLING CODE 4140-01-P
